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Abstract
Background: Anorexia nervosa is a severe, biologically based brain disorder with significant medical complications.
It is critical that new, effective treatments are developed to interrupt the persistent course of the illness due to the
medical and psychological sequelae. Several psychosocial, behavioral and pharmacologic interventions have been
investigated in adult anorexia nervosa; however, evidence shows that their impact is weak and treatment effects
are generally small.
Method: This paper describes a new neurobiological anorexia nervosa model that shifts focus from solely external
influences, such as social and family, to include internal influences that integrate genetic and neurobiological
contributions, across the age span. The model serves as a theoretical structure for a new, five-day treatment,
outlined in this paper, targeting anorexia nervosa temperament, which integrates neurobiological dimensions into
evidence-based treatment interventions. The treatment is in two phases. Phase I is a five day, 40 hour treatment for
anorexia nervosa adults. Phase II is the follow-up and is currently being developed.
Results: Preliminary qualitative acceptability data on 37 adults with anorexia nervosa and 60 supports (e.g., spouses,
parents, aunts, friends, partners, children of anorexia nervosa adults) are promising from Phase I. Clients with
anorexia nervosa and their supports report that learning neurobiological facts improved their understanding of the
illness and helped equip them with better tools to manage anorexia nervosa traits and symptoms. In addition,
nutritional knowledge changed significantly.
Conclusions: This is the first neurobiologically based, five-day treatment for adults with anorexia nervosa and their
supports. It is a new model that outlines underlying genetic and neurobiological contributions to anorexia nervosa
that serves as a foundation to treat both traits and symptoms. Preliminary qualitative findings are promising, with
both clients and supports reporting that the neurobiological treatment approach helped them better understand
the illness, while better conceptualizing how to respond to their traits and manage their symptoms. Data in Phase I
shows promise as a neurobiologically based intervention for anorexia nervosa, and it serves as a foundation for the
development of Phase II. Evidence of ongoing program efficacy will be described as data are reported on Phase II.
Trial registration: NCT NCT02852538 Registered 1 August 2016.
Plain english summary
This paper introduces a new, five-day treatment for
adults with anorexia nervosa and their supports that in-
tegrates neurobiological research with experiential treat-
ment tools. A new neurobiological model is introduced
that sets the stage for the possible genetic and brain
basis of this deadly illness. In addition, this intervention
“treats to the trait," addressing character traits common
to anorexia nervosa, such as perfectionism, anxiety and
inhibition, while working toward both short and long-
term management and change. Nutrition intervention
approaches "food as medicine" that "doses" the macronu-
trients. Pilot results found that there was a significant
improvement in nutritional knowledge between the be-
ginning and end of the week. Over 95 % of the clients
and supports reported they enjoyed learning about the
neurobiology of the illness and that they found the ex-
periential activities improved their understanding of an-
orexia nervosa. Over 95 % of the clients reported that
they felt their family/friends were equipped with better
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support tools and over 90 % of the supports and clients
reported the treatment both met or exceeded their ex-
pectations. Ideas on how this short-term intense inter-
vention could be integrated into ongoing eating disorder
treatment are explored.
Background
Anorexia nervosa is a severe, biologically based brain
disorder with significant medical risks [1] and a ten-
acious development over time. While onset is common
during puberty and adolescence, it also occurs through-
out adulthood [2, 3]. Up to 50 % of individuals with
anorexia nervosa develop a chronic course, characterized
by significant physical and psychological impairment
[4–8]. When the illness is active for five to seven years
or more, it becomes chronic and enduring [9]. The lon-
ger a person has anorexia nervosa, the harder it is to
overcome [10].
The development of effective treatments is of critical
importance to interrupt the persistent course of illness,
given the magnitude of medical and psychological seque-
lae. Brain imaging research has led to an increased
understanding of the etiology and neurobiological mech-
anisms underlying anorexia nervosa symptoms and has
identified potential targets of treatment, such as the
ventral striatal area. Despite this new perspective, there
are no interventions integrating the current, empirically
supported, biological findings into treatment.
Several psychosocial, behavioral and pharmacologic in-
terventions have been investigated in adult anorexia
nervosa; [4, 5, 11–15] however, evidence supporting
currently available treatments is weak, and treatment
effects, when found, are generally small [15–22]. Treat-
ment for adolescent anorexia nervosa is more promising,
with a large evidence base supporting family-based treat-
ment (FBT) [23–26]. Although the level of parental con-
trol prescribed in FBT is not well-suited for adult
individuals, elements of FBT may be beneficial for adult
treatments. Finding creative alternatives to integrate
support persons as agents of change becomes the chal-
lenge for adults who are more autonomous and often
have little to no support networks.
A new model that highlights the mechanistic path-
ways, constructs and traits underlying anorexia nervosa
psychopathology as one ages, as opposed to focusing
solely on a symptom-oriented approach, is in accord
with the National Institutes of Health (NIH) recom-
mended Research Domain Classification (RDoC). Such a
model could conceptualize a bio-genetic etiological
foundation for anorexia nervosa, to inform and guide
treatment approaches. For instance, white matter pre-
frontal cortex neural growth occurs until early thirties
[27]. Treatment for adults needs to address how the
brain can change through neuroplasticity, and to explain
that this process takes longer compared to adolescence.
If adults with anorexia nervosa learn about neurobio-
logical details that contribute to the neuropathway alter-
ations in a method that matches their manner of
thinking, in detail, then they may be open to accept the
need for more time and additional support to compen-
sate for what their body/brain cannot do, in spite of
their desire to overcome the illness alone.
This paper introduces a new anorexia nervosa model
that integrates genetic and neurobiological influences in
relation to social/external pressures for thinness across
the age span, and then introduces a new anorexia nervosa
adult treatment approach with supports (e.g., family,
friends) that experientially integrates anorexia nervosa tem-
perament with neurobiological research findings in a five-
day intensive treatment. The treatment targets adults with
anorexia nervosa or those who have a history of anorexia
nervosa and share common traits.
Philosophy on the use of neurobiology in
anorexia nervosa treatment
In order to make advances in adult anorexia nervosa
treatment, a paradigm shift is needed that includes
consideration of both the biological and the familial
dimensions for adult anorexia nervosa treatment. Target-
ing anorexia nervosa symptoms alone has not proven
effective. Therefore, targeting underlying neurobiological
mechanisms, that are core expressions of anorexia ner-
vosa traits, might show promise. It is hypothesized that
traits such as perfectionism, harm avoidance, anxiety
and inhibition manage personality and behavioral
responses are present prior to the development of an-
orexia nervosa and continue long after recovery [28–30].
These traits may be core maintaining or perpetuating
factors impeding treatment engagement and may be im-
portant in helping those who have long-standing, or se-
vere and enduring anorexia nervosa.
Additionally, persons with anorexia nervosa traits tend
to focus on details and are less capable of seeing the
global picture [31, 32]. For example, a child who has ob-
sessive and perfectionistic traits may repeatedly focus on
details in school assignments and find her/himself over-
whelmed with a multitude of choices. Uncertainty sets
in, as concern about making the “right” decisions
increases, as traits establish a stronger influence during
adolescence.[77] Those very traits could be sublimated to
help the adolescent and adult direct attention from
thoughts that appear to “freeze” or get “stuck,” from too
many options directed at them at the same time, to
thinking freely through selections when given fewer op-
tions. This approach could transform a problem into a
solution.
Similarly, the ability to make and trust decisions is crit-
ical for adolescents and adults to function autonomously
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in everyday life situations. The inability to make and trust
decisions is reported by many adult anorexia nervosa
clients in our treatment programs. Trust in one’s decisions
is diminished when a reduction in dopamine occurs in the
ventral limbic area of the brain [33–35]. If, through treat-
ment, clients learned the neurobiological contribution to
their inability to sense and make decisions, they might be
empowered to shift their understanding from self-blame to
focus on what is needed to compensate for brain misfiring.
In addition, explaining the biological basis of anorexia
nervosa may help clients shift fault from the difficulty
and inability to eat with ease, and reframe it to a
biological response that impacts their eating and deci-
sion making ability. Planning and structure can create a
method to augment difficulty in decision making.
A neurobiological model for anorexia nervosa
There have been significant advances in our understand-
ing of etiological influences associated with anorexia ner-
vosa. Genetic studies indicate that heritability accounts for
approximately 50–80 % of the risk of developing an eating
disorder (ED) [36]. Recent imaging studies reveal that in-
dividuals with anorexia nervosa tend to have common
temperament and personality traits related to neural
circuit function, which are heavily implicated in the devel-
opment and maintenance of the disorder [31, 34, 37–42].
The temperaments are characterized by increased trait
anxiety [43] and state anxiety related to food and eating,
[44] high incidence of co-morbid anxiety disorders, [43]
high punishment sensitivity and low reward reactivity,
[45] elevated intolerance of uncertainty [46] and exagger-
ated harm avoidance (HA). HA is a multifaceted tempera-
ment trait [47] that contains elements of anxiety,
inhibition and inflexibility [28–30, 48, 49]. There are mul-
tiple ways in which these traits may influence the etiology,
maintenance and treatment of the disorder. For example,
elevated anxiety and HA not only maintain ED symptoms,
but may predict poor treatment outcome; [28, 50–54] and
higher levels of pre-meal anxiety predict lower food intake
[44]. This is offset through the anxiolytic effect from acute
dietary restraint and caloric restriction [44, 55]. Food con-
sumption stimulates a dysphoric mood, [56] suggesting
that anorexia nervosa individuals may regulate eating be-
havior to manage anxiety.
A new anorexia nervosa model is proposed that re-
flects temperament and alterations in brain circuitry in
order to inform and help guide treatment interventions
(Fig. 1). This anorexia nervosa model shows heritable













































































Fig. 1 A Temperament-Based Model for Anorexia Nervosa
Hill et al. Journal of Eating Disorders  (2016) 4:31 Page 3 of 14
traits, such as harm avoidance, perfectionism, anxiety
and inhibition, establishing a temperamental basis from
which the illness may develop [28–30, 48, 49]. These
traits are initially expressed behaviorally in childhood.
Common temperamental expressions may include a nat-
ural compliance to rules within the family/school and
social settings. Likewise, perfectionism may be expressed
through high grades and excellent performance, and it
may be perceived as never good enough and experienced
with little reward sensation. Alterations in reward and
punishment reactivity also account for the tendency for
anorexia nervosa individuals to see their own errors over
their successes. Individuals with anorexia nervosa often
demonstrate a natural preference towards highly struc-
tured and predictable environments due to difficulties
with tolerating uncertainty and set-shifting. As such,
anxiety appears to reduce when children, adolescents
and adults with anorexia nervosa are provided with
structure verses open-ended and more ambiguous tasks.
These same traits also influence response to food for
individuals with anorexia nervosa. Individuals with an-
orexia nervosa tend to report that they do not experi-
ence a sense of reward in response to food intake, but
instead experience anxiety. As such, restriction of food
intake appears to provide an anxiolytic effect [57].
Recent research, including our own, has implicated
neural substrates in the ventral (lower or bottom area) lim-
bic circuitry, dorsal (top) cognitive circuitry and insula,
underlying altered reward processing [37, 58, 59], cognitive
or self-regulatory control [32, 60–62] and interoception
[41, 63–65] in the pathophysiology of anorexia nervosa
(Fig. 2). The ventral area of the limbic neural circuit in-
cludes the nucleus accumbens, putamen and caudate, as
well as the orbitofrontal cortex and amygdala. These
regions code for the rewarding and motivating value of
eating and contribute to approach or avoidance behaviors.
The dorsal cognitive network makes and executes de-
cisions, such as to control food consumption, based on
considerations of both short- and long-term outcomes
(e.g., perceived weight gain). It includes the dorsal caud-
ate and dorsal anterior cingulate, lateral prefrontal cor-
tex and parietal cortex. Specifically, the insula is a hub
for the evaluation of interoceptive cues, such as internal
pain, tastes or feelings of fullness, and plays a pivotal
role in anticipation and processing of interoceptive
states by conveying information about the internal
milieu of the person or organism [66, 67] and per-
ceived importance or salience of a food stimulus.
These systems interactively weigh the reward value of
food and consequences of consuming it, and integrate
this information with homeostatic and motivational
drives to guide eating behavior.
The model describes brain response changes for those
with anorexia nervosa from mounting evidence that in-
dicates that an altered balance of reward and inhibition
may contribute to disordered eating [1]. Figure 1 dem-
onstrates that in patients with anorexia nervosa, severely
restricted food intake appears to be related to overactive
inhibitory control (up inhibition arrow) in combination
with underactive reward circuitry (down interoception
and pleasure arrows). Imaging data further suggest that
anticipatory anxiety contributes to restricted eating. For
example, individuals with anorexia nervosa report exag-
gerated anxious and avoidance responses to food cues
[41, 44]. This is reflected in ventral striatal limbic
responses (up emotion arrow) [41] and implicates
elevated HA and anxiety in anorexia nervosa. This may
be expressed and experienced as cognitions becoming a
cacophony of “noise” impacting the inability to decide or
execute decisions, thus increasing doubt in the dorsal
caudate (up arrow). This also entails altered dopamine
(DA) and serotonin (5-HT) function. This disconnect
between anticipating and experiencing food stimuli likely
contributes to restricted eating in AN. Lowered dopa-
mine and increased serotonin response may also
contribute to the ability of persons with anorexia
nervosa to delay rewards since reward may be experi-
enced as less pleasurable [41].
Evidence also suggests parietal disturbance [68], which
codes for perception of body image and shape disturb-
ance increases (up body disturbance arrow); and the
motor cortex area implements the overactive anxiety
and body shape disturbance through excessive exercise
(up movement arrow). Together, these findings have im-
plications for motivation to eat and ability to evaluate re-
ward and make decisions. It is plausible that elevated
harm avoidance, perfectionism, anxiety and inhibition,
present during childhood, may increase the inclination
of compliance with rules for adults with anorexia
nervosa.
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Fig. 2 Areas of the Brain Involved in Eating
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The model shows that nurture, or environmental
influences, have more influence on the child’s tempera-
ment pre-puberty compared to post-puberty [58]. The
hypothalamic-pituitary gonadal axis initiates biological
changes during puberty, contributing to a shift from
nurture to nature taking the dominate role in trait
expression through mid-twenties [69]. This may trigger
changes in neurochemical circuity and contribute to
how thought patterns, emotions and motor expression
alter [70, 71]. In our view, to acknowledge that anorexia
nervosa tends to develop around puberty and may rise
in incidence again around 18, when faced with a multi-
tude of new life and daily decisions, is not enough to
understand the illness. In addition, the arrow on the
right, social and traumatic experiences, influence and
may even alter genetic expression during adolescent and
adult life, contributing to the development of anorexia
nervosa (shown as the arrow on the right in the Figure).
Neurobiological findings indicate and direct us to pos-
sible truths. However, research holds little value if clini-
cians and clients do not understand it or know how to
interpret it. Neurobiologically based research is new to
the treatment field and needs to be presented to
anorexia nervosa adults and their supports in a way
that they can understand the findings, so the client
can identify and determine how the findings relate to
their own experience. Interpreting research accurately
and creatively in a manner that enhances understand-
ing can lead to increased motivation, instead of resist-
ance, to change.
To date, anorexia nervosa clinical treatment ap-
proaches have not been developed and/or updated to
include both current neurobiological research findings
and family-based approaches for adults. The most widely
used behavioral treatment models, such as cognitive
behavioral therapy (CBT or CBT-Enhanced), focus on
symptomology. Biological underpinnings of the cogni-
tions and behaviors are given less to no focus.
Hence, what does a neurobiologically based adult
anorexia nervosa treatment look like?
Method: Overview of the NEW FED TR treatment
NEW FED TR is a five-day treatment for adults with an-
orexia nervosa. It is a neurobiologically informed, inter-
active, family-based treatment that draws upon the
specific etiological traits characterizing anorexia nervosa
[72]. It stands for Neurobiological research findings
Enhanced With Family/Friends of those with Eating
Disorders, addressing Trait Responses that both create a
vulnerability to the illness and serve as markers for
strength and recovery through treatment (formerly
reported as Temperament-Based Treatment). NEW FED
TR is being developed in two phases.
Phase I is for females or males who are 18 years old
and above (the program is expanding to 16 years old
and above), who have a history of anorexia nervosa or
current diagnosis of anorexia nervosa. Persons with a
current diagnosis of bulimia nervosa (BN) or binge
eating disorder (BED) and have a history of anorexia
nervosa may be in the treatment program if their
temperament is comprised of anorexia nervosa traits.
NEW FED TR requires at least one support person
(e.g., parent, spouse, partner or friend) and allows up to
four supports per client. The client and supports come to-
gether to learn about anorexia nervosa together with a
biological perspective and to explore why and how the
supports are needed.
It is an experiential treatment where all neurobio-
logical information is applied and integrated through
activities that provide a clear reliable structure that set a
foundation for safety while learning and practicing new
approaches to manage the traits and symptoms. Infor-
mation is presented in the manner that anorexia nervosa
clients tend to think: in detail, not in generalized points.
Clients are treated as the “experts” who know their
illness well, and thus have much to offer when specific
questions are asked by clinicians on how the neurobio-
logical research findings are experienced or apply to
them. This appears to transform resistance into client
motivation.
Phase II is the follow-up. It is being developed currently
by gathering input monthly from the clients and supports
who have completed Phase I. They identify what is add-
itionally needed for this phase and report how they are
eating and using the tools learned while functioning in
their home or other treatment settings.
How to best integrate Phase I into ongoing treatment,
or offer it as a free-standing program, is currently being
studied to determine best impact. Phase I has been
developed for those who meet criteria for partial hospital
program (PHP), intensive outpatient program (IOP) or
outpatient (OP) levels of care.
The development of Phase I has been over the last
four years and has been in preliminary testing over the
last two years. Client and support feedback have been
the foundation to refine and develop the client/support
manual, group sessions and neurobiological tools. The
suggestions for changes have evolved from many recom-
mendations for alterations to consistently requesting
that the schedule, activities, tools and manual remain
the same.
The clinical reliability has been established over the
past two years via open treatment trials, allowing the
treatment team to refine the schedule and neurobio-
logical content, approach to meals, movement and
Behavioral Agreement until they have been consistently
reported by clients and supports as above average to
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excellent as presented. Similarly, the average rating for
each hour of the treatment program, instruments and
client/support manual is “no changes recommended.”
The Behavioral Agreement is a 16 page treatment plan
written for and with the clients, supports and therapists
to establish a clear structured plan in response to pri-
mary anorexia nervosa traits and symptoms (Sample is
found as Additional file 1). It provides clients and sup-
ports with structure while addressing individual concerns.
It is a central tool that identifies how each client chooses
to manage their traits, tools and decisions when at home.
It also serves as a transitional treatment tool when leaving
NEW FED TR Phase I and entering Phase II.
An intent of Phase I is to provide detailed nutritional
information, neurobiologically based information and
tools that structure while drawing upon the ideas and
feedback from the supports and experts (clients). It is
the client and support who apply and practice the prac-
tical treatment methods to better manage anorexia
nervosa traits and symptoms at home or in ongoing
treatment. The supports hear the same information and
learn the same tools in tandem with the adult clients.
Their presence allows them to learn and practice the
tools at the same time as the clients.
To date, Phase I has been integrated or served as a
“jump-start” or “boost” at the beginning, middle or end
of an ongoing PHP, IOP or outpatient (OP) treatment,
based on client symptom severity. NEW FED TR has
also served as a stand-alone treatment because no other
eating disorder treatment was available. In these cases,
supports can be significant agents of change. They often
assume a greater role in ongoing assistance to help shift
the anorexia nervosa traits toward constructive expres-
sions over time. They also realize the importance of in-
creasing structure, planning, rules and rituals into daily
patterns. Follow-up data will help determine the impact
of Phase I in these multiple roles.
NEW FED TR has accepted clients with body mass in-
dexes (BMI) ranging from 13.81–30.4. It is recommended
that the five-day treatment, Phase I, be followed by add-
itional PHP, IOP or OP treatment depending on level of
severity. Ongoing monitoring of food intake, body compos-
ition/weight and symptoms, as well as facilitation of contin-
ued use of clinical tools, is essential. The supports are
appearing to be a central source in helping the anorexia
nervosa client transition with continuity into the home
setting, even if the supports live in different locations.
Clinicians who assume the client for treatment at their
home sites are asked to adopt the Behavioral Agreement
established during NEW FED TR and integrate the de-
tails that are clearly laid out by the client and supports.
This has had varying responses from different clinicians
ranging from openly welcoming the treatment tools and
Behavioral Agreement and including family and supports
in ongoing treatment to rejecting and ignoring the Be-
havioral Agreement and supports in their practice. It has
also been stated repeatedly by anorexia nervosa clients
leaving NEW FED TR that the clinicians at their home
sites know little to no anorexia nervosa neurobiological
information to help them better manage the illness.
A NEW FED TR therapist manual is near completion.
It outlines and details every point made during NEW
FED TR to aid in consistency across treatment sites. In
addition, there is a completed client and support NEW
FED TR manual that has been endorsed from client and
support feedback. It is used throughout each day of
Phase I and taken home at the end of the five-day
treatment.
NEW FED TR phase 1: Five-day treatment outline
NEW FED TR consists of five daily modules aimed at
targeting anorexia nervosa trait constructs, delivered
with clients, supports and treatment providers. Each
module is formatted to deliver: 1) interactive, neurobio-
logical psychoeducation; 2) tools used within a neurobio-
logical context to compensate for brain deficits and
facilitate constructive methods for redirecting tempera-
ment expression; 3) support management strategies; 4)
experiential learning focused on practicing the imple-
mentation of the tools that can become skills; and 5) an
approach to food as medicine by “dosing” the macronu-
trients. See Fig. 3 to review the NEW FED TR schedule
by modules. The details to the modules and how they
are structured in treatment are described in the therapist
manual, which is in the final stages of being written.
Every hour of each of the five days the clients, sup-
ports and therapy team work together to learn, experi-
ence, practice and establish a practical, livable structure
for food and daily life activities at home. The only excep-
tion is Module 3, where the clients and supports enter
separate groups to learn and practice new tools among
peers. Clients empathically explore their thoughts, feel-
ings and behaviors together while learning new thera-
peutic tools. Simultaneously, supports learn and apply
new tools with one another. They draw upon group
members' support and understanding regarding difficult
and complex life situations.
Role of the treatment team and census
The comprehensive treatment team is comprised of the
client; the clients’ family, friends, partners and others
who serve as primary supports; and clinical eating dis-
order therapists, dietitians and medical staff. Adults with
anorexia nervosa are viewed as the experts.
At least one support (the same person) is required to
be present every hour of the 40 hours, so that all partici-
pants are hearing the information and ideas together
and everyone is participating in practicing what each
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Fig. 3 Schedule
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member can do to contribute to change. Clinicians from
the clients’ home sites are allowed to participate as a
support or team member. This enhances treatment
consistency. The intensive nature of Phase I is intended to
immerse the client and supports with experiential learn-
ing, apply and practice tools every hour, practice food
preparation and use movement or “walk-abouts” after
meals with a trained therapy team interpreting key factors
involved in brain and body recovery.
Adults with anorexia nervosa tend to want to “go it
alone,” avoid help or are hesitant to ask for support from
those they know. They often report fearing that their
spouses, parents or friends will “hover too much” or take
control of their lives. Keeping the supports from partici-
pating encourages the anorexia nervosa fears and pre-
vents supports from learning what they can do, and not
do, to help their loved ones. Supports are not only a
form of intervention and growth during and after treat-
ment, they become agents of change, helping the adult
with anorexia nervosa enter treatment.
The treatment is comprised of up to six anorexia ner-
vosa adult clients with up to four supports per client
working together in a multi-support group format. This
totals up to 24 clients and supports with three clinicians,
one dietitian and one medical staff person, plus nutri-
tional and administrative assistants. The group format
allows both clients and supports to see similar qualities
in one another that help validate feelings and encourage
motivation for change while including the client and
supports as experts who have lived with the illness and
know it from many angles. It assumes the total team
holds creative answers for solutions while the program
models, throughout the treatment week, also take a team
to “manually” change adult anorexia nervosa traits and
symptoms until possible future neurobiological advances
can be made.
Role of neurobiology and temperament in
treatment
NEW FED TR “treats to the traits” throughout each day
via experiential, neurobiologically based activities and
playful clinical tools. The mental, and at times physical,
pain from eating is acknowledged and used experien-
tially and made malleable by transforming it through
play. The treatment approach acknowledges that under-
lying traits are persistent through life (versus transitory),
and focuses on teaching adults with anorexia nervosa
and their supports to manage anorexia nervosa symp-
toms by using their traits constructively (versus destruc-
tively through the pursuit of emaciation). One NEW
FED TR client shared, “Anorexic individuals, who may
be men or women, are both terrified of and obsessed
with food…Therefore, the Center has resolved to treat
food as medicine. Our meal plans are ‘prescriptions’ and
each of us must take a certain number of ‘doses’ of each
macronutrient per day…The irony is that this program
teaches anorexics to use the exact method that led us
into our illness to bring us out of it. All the planning,
calculating and perfecting that was once used to chip
away at ourselves can also be used to achieve optimal
health.”
Neurobiological research facts are explained and inte-
grated into a group family-based therapy (FBT) format
for adults, synthesizing evidence-based dialectical behav-
ioral therapy (DBT) and cognitive behavioral therapy
(CBT) tools into experiential activities that have been
tested with clients and supports. Figure 4 visually de-
scribes how neurobiological information is approached
in NEW FED TR in relation to other forms of treatment,
support persons and the Behavioral Agreement. The
treatment approaches neurobiology as the hub of a
wheel, out of which CBT, DBT, and other treatment
brain-based tools can be applied. The neurobiological
findings helps explain why the clients need to use the
treatment tools, and the role supports, medication and
the Behavioral Agreement play, to hold the structure
and trait management in place. The therapy team
approaches the clients and supports from a perspective
of “I need your help to figure out if this applies to you.”
Asking their input on what their experiences are like
allows for the clients’ voices to be heard in a context of
the expert.
In addition, real-time client and support interactions
during target events such as mealtimes, acute emotional
distress, behavioral resistance and family interactions
allow for both clients and supports to receive applicative,
Client Neurobiology Families/Friends
Fig. 4 How Neurobiological Findings Relate to Other Treatment
Tools and the Behavioral Agreement
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hands-on experience to refine management skills. The
intensity of intervention is designed to capitalize on te-
nets of neuroplasticity that require increased consistency
and clear structure as critical components needed to
elicit behavior change for anorexia nervosa [73, 74].
A Behavioral Agreement (Additional file 1) instrument
has been developed and validated that integrates neuro-
biological concepts and findings into a detailed structure
to help each client decide what s/he wants to change the
most and what actions are most and least helpful to
make that change for themselves, the supports and for
other therapy, medical and nutritional team members.
Client feedback has refined it to the place that the ma-
jority report “I would not change a word, this is what I
think is true for me.” It is more detailed and structured
than other treatment approaches. For example, it offers
multiple choices instead of open ended questions that
address the identified and prioritized goals.
Neurobiologically based tools (Module 2)
The clients discover through neurobiologically based
experiential tools that improving their health means
there is increased struggle mentally, interpersonally and
perceptually, not less. While other diagnoses, such as
depression and anxiety, bring greater peace and calm as
the person improves, anorexia nervosa is the opposite.
More distress is experienced the more one eats to im-
prove their physical health state. This struggle is ex-
plained through several different experiential activities,
such as the Non-Dominant Hand [75].
The clients and supports participate in a guided activ-
ity writing different phrases with their non-dominant
hands. All clients and supports are asked to share what
they feel as they write with their non-dominant hand.
Common responses include: awkward, stupid, slow, in-
capable, irritated, inept and frustrated. The analogy is
made that eating, for those with anorexia nervosa, is a
non-dominant action and response. During the activity,
the clients consistently validate that the eating experi-
ence encompasses the very feelings the supports re-
ported when writing with their non-dominant hand. The
supports report realizing the difficulty that their loved
ones feel when eating what appears to be “normal foods”
and “normal amounts of food.”
Supports are asked what they would do if they were
told they had to write with the non-dominant hand the
rest of their life. Many report they would stop writing,
and the analogy is then realized regarding the day after
day struggle their loved ones experience when eating.
Clients with anorexia nervosa report they do not feel
better when eating what is needed for their bodies, they
feel worse, and that this activity helps them to help the
supports better understand and begin to explore what
actions are needed to cope with and manually help the
clients to eat. Practice becomes the identified and pro-
verbial key to tolerate the foods. The clients are expected
to eat, even though it is a “non-dominant” brain response,
by eating enough food for the rest of their lives.
As one client wrote on what helped the most that
day in treatment, “The experiential exercise. So im-
portant for support people to get a taste of what
people with anorexia go through on a daily basis.” A
support person wrote, “[The] illustration of the diffi-
culty experienced by my daughter - in how learning
what she is feeling and thinking - her response and
those of others when it came to the surface in the
group discussion.”
This illness of anorexia nervosa is described as learn-
ing to “take their medicine,” which is food. Food has
“side effects” in the brain. Thus at times, chemical medi-
cations are needed to treat the “side effects” of their
primary medication, food. Hence, anorexia nervosa
appears to be an illness that induces a complex struggle
to progress toward health.
Other neurobiologically based activities that have been
tested and refined from client and support feedback over
the last five years include: Telephone, Anxiety Wave,
The Landmine, Wire Rewire, The Brain Wave [75] and
The Gauntlet.
Nutritional intake: Food is medicine and
macronutrients are “dosed” (Module 5)
The clients engage in a nutritional assessment prior to
entering the program. Their body weight/composition
serves as a foundation in establishing their meal plans,
along with their value/philosophy around food. For ex-
ample, if they report being vegetarian or vegan, that was
honored and their meal plans incorporated that ap-
proach. The approach to food in NEW FED TR is that
food is medicine and the macronutrients are “dosed.”
The message is that since eating disorders are biologic-
ally based, then approaching food as medicine is similar
to approaching insulin in doses as one does with dia-
betes. The meal plan becomes the “prescribed macronu-
trient combinations and amounts” that are matched to
the client’s activity and body composition with the aim
to establish a healthier body for the identified life activ-
ities established in the Behavioral Agreement [76].
Each client prepares their own meals and selects their
own snacks each day of the treatment, with their supports
learning and assisting beside them. Supports also prepare
their own meals. The clients prepare and apply the macro-
nutrient “doses” they are “prescribed” by the dietitian and
supports learn and then practice each meal on how the
meal reflects the dosed amounts. For example, a breakfast
may be a “3,2,1” dose, being three carbohydrates, two pro-
teins and one fat. Fats are described in the program as
“endurance fuels” or “EFs” [76]. The program aims to
Hill et al. Journal of Eating Disorders  (2016) 4:31 Page 9 of 14
provide foods similar to what the clients can purchase and
use at their home sites to help with transition from treat-
ment to home. As one client reported in the end of the
week feedback, “I loved that I had the ability to choose the
foods that fit my meal plan. It was more realistic to have
normal grocery store food to simulate what it would be
like at home.”
A Nutritional Facts Questionnaire was developed by
the eating disorder dietary team who were involved in
the program development. The nutritional facts used in
the questionnaire were based on macronutrients “dosed”
in units, drawing from the American Dietetic Associ-
ation Exchange Lists for meal planning (See Additional
file 2 to review the questionnaire and scoring instruc-
tions). Both clients and supports are tested on nutri-
tional facts applied in the treatment to assure the same
information was learned and practiced at home by both
parties and to encourage consistency. By dosing foods
with supports’ oversight, there may be less risk for cli-
ents to cut back on needed macronutrients.
Results: Preliminary data
The study has been the development and collection
of preliminary data for Phase I of this treatment pro-
gram. It was approved by the institutional review
board of the University of California, San Diego, and
all participants gave written informed consent to
participate.
Inclusion criteria include persons who exhibit current
symptoms of anorexia nervosa, both restrictor and binge
and/or purging subtypes; or have had a history of an-
orexia nervosa. The treatment program included all gen-
ders, ages 18 years and above.
This paper reports on data from 37 clients (36 females
and one male; mean age = 23.2, range = 18-47; mean
illness duration = 8.5 years, range = 1-40 years; mean base-
line BMI = 18.3 kg/m2, range = 13.8-22 kg/m2) and 60
supports who completed acceptability and liking ratings
after the five-day treatment. Diagnoses were confirmed
by using the Structured Clinical Interview for the
Diagnostic and Statistical Manual of Mental Disor-
ders, DSM-5 (SCID). Pretesting occurred the weekend
prior to the five-day treatment, and post-testing
followed on Friday evening or Saturday after treat-
ment. In addition to a battery of standardized tests
measuring traits, eating disorder symptoms and
weight, daily qualitative information was gathered on
what helped the most, what helped the least and what
was their primary “take home” message at the end of
each day and the end of the week.
The clients and supports are from 17 states and 4
countries, primarily the USA (47 clients). One client and
her mother stepped out of treatment after one day due
to a family member’s medical emergency, resulting in a
two percent (n = 1 patient, 1 support) attrition rate in
our study, which is lower than around the 30–40 %
drop-out rate reported from other treatment studies,
which is most probably due to the very short time span
of the program [77].
Preliminary qualitative data indicate good acceptability
of the neurobiological information presented (see Fig. 5).
Ninety-two percent of the clients and 98 % of the sup-
ports would recommend NEW FED TR to others.
Ninety-seven percent of the clients and 97 % of the sup-
ports reported they enjoyed learning about the neuro-
biology of eating disorders. Ninety-seven percent of the
clients and 97 % of the supports reported the neurobio-
logical exercises improved their understanding of
anorexia nervosa. Ninety-five percent of the clients re-
ported that they felt their family/friends were equipped
Support
Client
Fig. 5 Qualitative Data on the Acceptability of Neurobiological Information from anorexia nervosa Adult Clients and Supports
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with better support tools and 100 % of supports
reported feeling equipped with better support tools.
Ninety-one percent of the clients and 98 % of the
supports reported that this treatment met their
expectations.
There was a significant improvement in learning how
to “dose” foods when approaching “food as medicine,”
using macronutrients to assure balance in meals. Pre- to
post-testing changes in nutritional knowledge in the 32
patients with data resulted in pre mean = 60.2 % accur-
acy (SD = 21.4), post mean = 78.5 % accuracy (SD = 13.5),
t(31) = 5.13, p < 0.001. For the 39 supports who com-
pleted the nutritional testing, pre mean = 53.7 % accur-
acy (SD = 17.0), post mean = 70.7 % accuracy (SD = 10.9),
t(38) = 6.11, p > 0.001.
Additional qualitative information on what helped the
most during the week and what helped the least during
the week are representatively reported by having ran-
domly selected five clients’ and five supports’ feedback
for each question (see Table 1). Both clients and sup-
ports reported strong and encouraging feedback, with
few to minimal concerns for change. The qualitative
feedback holds caution in that what is true in the mo-
ment at post-testing, may not be true in six months to a
year. However, the feedback of Phase I provides a basis
for clinical validity for treatment content and interac-
tions, approach to food and the neurobiological basis of
Phase I.
Discussion
The NEW FED TR preliminary results indicate that
adult clients with anorexia nervosa and their supports
have a strong desire to learn more detailed information
about the neurobiology and biological basis of this ill-
ness. As one NEW FED TR mother stated, “Understand-
ing the current neurobiology is critical to family/friend
supporters - no excuse not to get this understanding in
all treatment programs today. And, for me, this deep un-
derstanding had to be explained beyond reading a scien-
tific journal article or watching a PowerPoint.”
Over 90 % of the clients and supports reported that
their expectations were met through this new treatment
approach. The new, neurobiologically based, experiential
treatment tools were well received and evaluated with
over 95 % of the participants responding that they
agreed or strongly agreed that the tools improved their
understanding of the illness. In addition, there was an
overwhelming response that both clients and supports
would recommend the program to others.
Conclusions
To date there are little to no effective treatments for
adults with anorexia nervosa. Neurobiological research
has shifted our understanding of anorexia nervosa from
primarily an outside-in, to now include an inside-out,
brain-based illness that can be severe, enduring and
fatal. Treatment needs to reflect, integrate and
synthesize neurobiological underpinnings into ongoing,
evidence-based approaches. A new, trait-based model for
anorexia nervosa is described, which outlines the genetic
and neurobiological vulnerabilities that influence eating
disorder development over one’s age span. This model
Table 1 Random Selection of Clients’ and Supports’ Comments
of What Helped the Most and the Least
NEW FED TR Clients
What helped the most? What helped the least?
The way the brain functions.
The noisy brain.
Honestly nothing, and I mean that.
Putting together a treatment plan,
discovering the internal workings
within the brain, and finding new
ways to look at and talk about
nutrition.
Nothing
Interaction with other families,
neuro education, role playing.
[Redacted] is always so incredibly
helpful. I think 4 families was a
good number.
I didn't really like the DBT sessions -
didn't find them that helpful
I have never approached recovery
this way and I am hoping it's the
way that will work for me.
Nothing. Only regret was not
having more time to attend.
Family support based - I will be
accountable. Intense, quick -
packed with evidence based
program. Amazing staff.
[Redacted]…life changers.
The contract is great.
Eliminates questions later.
More heads up BEFORE coming to
the program about what the meal
plan will be like to minimize the
big change/transition to the new
meal plan.
NEW FED TR Supports
What helped the most? What helped the least?
So much useful information to
practice and take home.
Honestly, I understand the benefit
to you of getting this feedback and
I have struggled with these end-of-
day questions.
The program approaches the
illness with scientific data.
Solutions are good. For the first
time, I see an end to this illness.
Really can't say there was anything
I didn't like it was a great program.
One on one with team. Brain
science studies and examples
(restaurant).
(blank)
Being educated about the illness,
the meal plan as medicine, making
room per individualization, being
able to share with other clients
and families, the individual therapy
session.
Suggest to have [redacted] review
the study protocol on Sunday during
pre-testing. Also, more structure for
dinner Sunday night during pretesting.
[Redacted]’s presentation on the
brain function for a patient with
ED. Learning more about MY
daughter, and why she does what
she does - also how to manage
recovery. The contract.
Down time
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outlines a foundation for a new, five-day, 40 hour, treat-
ment for clients with anorexia nervosa and their sup-
ports called NEW FED TR. It integrates neurobiological
information and tools within evidence-based family-
based treatment, dialectical behavioral therapy and en-
hanced cognitive behavioral therapeutic approaches.
Preliminary qualitative findings reveal that participants
agreed or strongly agreed that the neurobiological infor-
mation was helpful and activities augmented ways to in-
tegrate new behavioral patterns into the lifestyles of the
clients and families.
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